Study protocol: Assessing the association between corporate financial influence and implementation of policies to tackle commercial determinants of non-communicable diseases: A cross-sectional analysis of 172 countries

Simple item page
buir.contributor.authorWigley, Simon
buir.contributor.orcidWigley, Simon|0000-0001-9181-0129
dc.citation.epage5en_US
dc.citation.issueNumber8en_US
dc.citation.spage1en_US
dc.citation.volumeNumber12en_US
dc.contributor.authorAllen, Luke Nelson
dc.contributor.authorWigley, Simon
dc.contributor.authorHolmer, Hampus
dc.date.accessioned2023-03-01T07:47:21Z
dc.date.available2023-03-01T07:47:21Z
dc.date.issued2022-08-30
dc.departmentDepartment of Philosophyen_US
dc.description.abstractIntroduction There are many case studies of corporations that have worked to undermine health policy implementation. It is unclear whether countries that are more exposed to corporate financial influence are systematically less likely to implement robust health policies that target firms' financial interests. We aim to assess the association between corporate financial influence and implementation of WHO-recommended policies to constrain sales, marketing and consumption of tobacco, alcohol and unhealthy foods. Methods and analysis We will perform a cross-sectional analysis of 172 WHO Member States using national datasets from 2015, 2017 and 2020. We will use random effects generalised least squares regression to test the association between implementation status of 12 WHO-recommended tobacco, alcohol and diet policies, and corporate financial influence, a metric that combines disclosure of campaign donations, public campaign finance, corporate campaign donations, legislature corrupt activities, disclosure by politicians and executive oversight. We will control for GDP per capita, population aged >65 years (%), urbanisation (%), level of democracy, continent, ethno-linguistic fractionalisation, legal origin, UN-defined 'Small Island Developing States' and Muslim population (%) (to capture alcohol policy differences). We will include year dummies to address the possibility of a spurious relationship between the outcome variable and the independent variables of interests. For example, there may be an upward global trend in policy implementation that coincides with an upward global trend in the regulation of lobbying and campaign finance. Ethics and dissemination As this study uses publicly available data, ethics approval is not required. The authors have no conflicts of interest to declare. Findings will be submitted to a peer-reviewed journal for publication in the academic literature. All data, code and syntax will be made publicly available on GitHub. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.en_US
dc.identifier.doi10.1136/bmjopen-2021-055656en_US
dc.identifier.issn20446055
dc.identifier.urihttp://hdl.handle.net/11693/111983
dc.language.isoEnglishen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.isversionofhttps://dx.doi.org/10.1136/bmjopen-2021-055656en_US
dc.source.titleBMJ Openen_US
dc.subjectEpidemiologyen_US
dc.subjectHealth policyen_US
dc.subjectPublic healthen_US
dc.titleStudy protocol: Assessing the association between corporate financial influence and implementation of policies to tackle commercial determinants of non-communicable diseases: A cross-sectional analysis of 172 countriesen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Study_protocol_Assessing_the_association_between_corporate_financial_influence_and_implementation_of_policies_to_tackle_commercial_determinants_of_non-communicable_diseases_A_cross-sectional_analysis_of_172_countries.pdf
Size:
312.44 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.69 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Department of Philosophy